GGrantIndex
← Leaderboards

John Heiss

National Institute Of Neurological Disorders And Stroke

$0
Attributed
$0
Total exposure
0
Grants
0
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding mix

By agency

By mechanism

Top collaborators

No co-investigators on record.

Others in their field

Top investigators on “Publishing

Research focus

PublishingTumorReportingOperative Surgical ProceduresStructureMagnetic Resonance ImagingClinical ResearchGeneticBrainFutureParalysedNatural HistoryEtiologyAffectCharacteristicsPathway InteractionsResearch PersonnelFamilyEnrollmentSpinalCollaborationsRelating To Nervous SystemObstructionNeuro-Oncology

Grant awards (31)

Pathophysiology and Treatment of Syringomyelia$985,738
ZIA · FY2025 · NS · contact PI
Molecular Pathogenesis of Neoplasia$872,468
ZIA · FY2025 · NS · contact PI
Central Nervous System Drug Delivery Techniques$177,510
ZIA · FY2025 · NS · contact PI
Pathophysiology and Treatment of Syringomyelia$1,183,526
ZIA · FY2024 · NS · contact PI
Molecular Pathogenesis of Neoplasia$1,040,298
ZIA · FY2024 · NS · contact PI
Central Nervous System Drug Delivery Techniques$197,254
ZIA · FY2024 · NS · contact PI
Pathophysiology and Treatment of Syringomyelia$1,053,048
ZIA · FY2023 · NS · contact PI
Molecular Pathogenesis of Neoplasia$953,971
ZIA · FY2023 · NS · contact PI
Central Nervous System Drug Delivery Techniques$199,564
ZIA · FY2023 · NS · contact PI
Molecular Pathogenesis of Neoplasia$1,839,017
ZIA · FY2022 · NS · contact PI
Pathophysiology and Treatment of Syringomyelia$726,257
ZIA · FY2022 · NS · contact PI
Central Nervous System Drug Delivery Techniques$199,141
ZIA · FY2022 · NS · contact PI
Molecular Pathogenesis of Neoplasia$1,639,115
ZIA · FY2021 · NS · contact PI
Pathophysiology and Treatment of Syringomyelia$1,427,442
ZIA · FY2021 · NS · contact PI
Central Nervous System Drug Delivery Techniques$237,442
ZIA · FY2021 · NS · contact PI
Pathophysiology and Treatment of Syringomyelia$1,152,584
ZIA · FY2020 · NS · contact PI
Neurooncology of Benign Central and Peripheral Nervous System Tumors$732,289
ZIA · FY2019 · NS · contact PI
Pathophysiology and Treatment of Syringomyelia$717,512
ZIA · FY2019 · NS · contact PI
Pathophysiology and Treatment of Syringomyelia$699,667
ZIA · FY2018 · NS · contact PI
Neurooncology of Benign Central and Peripheral Nervous System Tumors$690,950
ZIA · FY2018 · NS · contact PI
Neurooncology of Benign Central and Peripheral Nervous System Tumors$588,894
ZIA · FY2017 · NS · contact PI
Pathophysiology and Treatment of Syringomyelia$538,651
ZIA · FY2017 · NS · contact PI
Neurooncology of Benign Central and Peripheral Nervous System Tumors$811,713
ZIA · FY2016 · NS · contact PI
Pathophysiology and Treatment of Syringomyelia$811,713
ZIA · FY2016 · NS · contact PI
Neurooncology of Benign Central and Peripheral Nervous System Tumors$801,677
ZIA · FY2015 · NS · contact PI
Pathophysiology and Treatment of Syringomyelia$801,677
ZIA · FY2015 · NS · contact PI
Neurooncology of Benign Central and Peripheral Nervous System Tumors$815,953
ZIA · FY2014 · NS · contact PI
Pathophysiology and Treatment of Syringomyelia$815,953
ZIA · FY2014 · NS · contact PI
Pathophysiology and Treatment of Syringomyelia$1,036,604
ZIA · FY2013 · NS · contact PI
Neurooncology of Benign Central and Peripheral Nervous System Tumors$1,036,604
ZIA · FY2013 · NS · contact PI
Pathophysiology and Treatment of Syringomyelia$520,984
ZIA · FY2012 · NS · contact PI